Stem cell therapies in the clinic

被引：1

作者：

Acharya, Shrinivas ^{[1
,2
]}

Shaha, Suyog ^{[1
,2
]}

Bibbey, Michael Griffith ^{[1
,2
]}

Mukherji, Malini ^{[1
,2
]}

Zhao, Zongmin ^{[3
]}

Mitragotri, Samir ^{[1
,2
]}

机构：

[1] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Allston, MA 02138 USA

[2] Harvard Univ, Wyss Inst Biolog Inspired Engn, Boston, MA 02115 USA

[3] Univ Illinois, Coll Pharm, Dept Pharmaceut Sci, Chicago, IL 60607 USA

来源：

BIOENGINEERING & TRANSLATIONAL MEDICINE | 2025年

基金：

美国国家卫生研究院; 美国国家科学基金会;

关键词：

cell; cell therapy; clinical translation; clinical trials; HSC; iPSC; MSC; stem cell; PROOF-OF-CONCEPT; BONE-MARROW; STROMAL CELLS; DIABETES-MELLITUS; TRANSPLANTATION; EFFICACY; PROGRESS; SAFETY; DONOR; OSTEOARTHRITIS;

D O I：

10.1002/btm2.70000

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Stem cell therapies have emerged as a transformative approach in modern medicine, with the potential to address and possibly cure a broad spectrum of diseases. These therapies utilize living stem cells that can perform complex biological functions not replicable by traditional drugs. Stem cell therapies have an expanding therapeutic landscape, with several products already approved and numerous clinical trials underway. Among the various stem cell types, hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) are most widely studied. In this review, we provide a detailed analysis of the current clinical landscape of stem cell therapies. We review 27 stem cell products that have received regulatory approvals and discuss 800 ongoing clinical trials, with a focus on HSCs and MSCs. We also discuss the critical challenges to be addressed to facilitate the clinical translation of stem cell therapies.

引用

页数：25

共 50 条

[1] Cell therapies in the clinic
Wang, Lily Li-Wen
Janes, Morgan E.
Kumbhojkar, Ninad
Kapate, Neha
Clegg, John R.
Prakash, Supriya
Heavey, Mairead K.
Zhao, Zongmin
Anselmo, Aaron C.
Mitragotri, Samir
BIOENGINEERING & TRANSLATIONAL MEDICINE, 2021, 6 (02)
[2] Translating stem cell therapies to the clinic
Miller, Robert H.
Bai, Lianhua
NEUROSCIENCE LETTERS, 2012, 519 (02) : 87 - 92
[3] Prospects for pluripotent stem cell therapies: Into the clinic and back to the bench
Grabel, Laura
JOURNAL OF CELLULAR BIOCHEMISTRY, 2012, 113 (02) : 381 - 387
[4] Peripheral stem cell therapies in decompensated liver disease
Gu, Jingtao
Lv, Liangshan
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (10): : 10380 - 10387
[5] Clinical Trials with Mesenchymal Stem Cell Therapies for Osteoarthritis: Challenges in the Regeneration of Articular Cartilage
de Carvalho Carneiro, Diego
de Araujo, Lila Teixeira
Santos, Girlaine Cafe
Damasceno, Patricia Kauanna Fonseca
Vieira, Jaqueline Leite
dos Santos, Ricardo Ribeiro
Barbosa, Josiane Dantas Viana
Soares, Milena Botelho Pereira
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
[6] Management of Rheumatoid Arthritis: Possibilities and Challenges of Mesenchymal Stromal/Stem Cell-Based Therapies
Shimizu, Yusuke
Ntege, Edward Hosea
Azuma, Chinatsu
Uehara, Fuminari
Toma, Takashi
Higa, Kotaro
Yabiku, Hiroki
Matsuura, Naoki
Inoue, Yoshikazu
Sunami, Hiroshi
CELLS, 2023, 12 (14)
[7] Clinical trials for stem cell therapies
Trounson, Alan
Thakar, Rahul G.
Lomax, Geoff
Gibbons, Don
BMC MEDICINE, 2011, 9
[8] Stem cell therapies for wound healing
Kosaric, Nina
Kiwanuka, Harriet
Gurtner, Geoffrey C.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (06) : 575 - 585
[9] Stem cell therapies for autoimmune hepatitis
Lotfy, Ahmed
Elgamal, Aya
Burdzinska, Anna
Swelum, Ayman A.
Soliman, Reham
Hassan, Ayman A.
Shiha, Gamal
STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
[10] Vascular disease and stem cell therapies
Lasala, Gabriel P.
Minguell, Jose J.
BRITISH MEDICAL BULLETIN, 2011, 98 (01) : 187 - 197

← 1 2 3 4 5 →